期刊文献+

高血压大鼠肾脏基质金属蛋白酶及组织型基质金属蛋白酶抑制剂表达与活性的变化 被引量:3

Changes of expression and activity of renal matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the stroke-prone spontaneously hypertensive rats
原文传递
导出
摘要 【目的】研究在卒中易感型自发性高血压大鼠(stroke-prone spontaneously hypertensiverat,SHR-SP)肾脏中,基质金属蛋白酶(Matrixmetalloproteinases,MMPs)-2,-9以及组织型基质金属蛋白酶抑制剂(tissue inhibitors of matrix metalloproteinases,TIMPs)-1,-2的表达与活性的变化。【方法】分别采用40只7周龄雄性SHR-SP大鼠及10只同周龄雄性Wistar-Kyoto大鼠作为高血压组与阴性对照组。观察期间定期测量各组大鼠无创鼠尾压。6个月后,处死存活大鼠留取血液及肾脏标本,测定血清肌酐及尿素氮浓度,采用组织病理染色观察两组大鼠肾脏组织学改变,采用明胶酶谱法分析存活大鼠肾脏MMP-2和MMP-9蛋白活性,并采用逆明胶酶谱法及蛋白质印迹分析TIMP-1和TIMP-2蛋白表达和活性。【结果】(1)明胶酶谱分析显示:SHR-SP肾脏中MMP-2活性较WKY组明显增高([3.28±1.17)vs.(1.26±0.62);P<0.01]。(2)逆明胶酶谱分析显示:高血压大鼠肾脏TIMP-2的活性明显高于WKY组([1.12±0.43)vs.(0.78±0.34),P<0.05]。(3)蛋白质印迹结果显示:高血压组大鼠肾脏TIMP-1、TIMP-2表达较对照组高([TIMP-1:(3.44±0.13)vs.(2.31±0.15),TIMP-2:(6.44±0.49)vs(.4.94±0.68),P<0.01]。【结论】SHR-SP肾脏组织中MMP-2及TIMP-2的活性增高,TIMP-1及TIMP-2的表达均明显升高。 [Objective] To investigate the expression and the activity of renal matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases in stroke-prone spontaneously hypertensive rats (SHR-SPs). [Methods] 40 male SHR-SPs of 7 weeks old were used as vehicle group and 10 male Wistar-Kyoto rats (WKY) at the same age were used as controls. Throughout the intervention, indirect tail-cuff systolic blood pressure was continuously measured. The survival rats were executed 6 months later. After the blood was collected to measure the plasma creatinine and urea nitrogen, some kidneytissues were embedded for pathological analysis. The activity of MMP-2 and MMP-9 were detected by gelatin zymography, The expression and the activity of tissue inhibitors of matrix metalloproteinase were detected by western blot and reverse zymography. [ Results] (1) Analysis of the activity of MMPs in kidney by zymography demonstrated that the activity of MMP-2 was markedly increased as compared with control group[(3.28 ± 1.17) vs. ( 1.26 ± 0.62); P 〈 0.01]. (2) The result of reverse zymography demonstrated that the activity of TIMP-2 was also increased in SHR-SPs[( 1.12 ± 0.43 ) vs. (0.78 ± 0.34), P 〈 0.05]. (3) Analysis of the expression of TIMPs in kidney by western blot demonstrated that the expression of TIMP-1 and TIMP-2 in SHR-SPs group was markedly increased as compared with controls [(TIMP-I: (3.44 ± 0.13) vs. (2.31 ± 0.15), TIMP-2:(6.44 ± 0.49) vs. (4.94 ± 0.68), P 〈 0.01]. [Conclusion]The results of present study showed that the activity of MMP-2, TIMP-2 and the expression of TIMP-1,-2 in the kidney of SHR-SPs were markedly increased.
出处 《武警后勤学院学报(医学版)》 CAS 2013年第3期161-165,F0004,共6页 Journal of Logistics University of PAP(Medical Sciences)
关键词 高血压 基质金属蛋白酶 组织型基质金属蛋白酶抑制剂 肾纤维化 Hypertension Matrix metalloproteinases Tissue Inhibitors of matrix metalloproteinases Renal fibrosis
  • 相关文献

参考文献17

  • 1Tan R J,Liu Y.Matrix metalloproteinases in kidney homeo-stasis and diseases [J].Am J Physiol Renal Physiol,2012,302(11):F1351-61.
  • 2Musial K,Zwolinska D.Matrix metalloproteinases(MMP-2,9)and their tissue inhibitors(TIMP-1,2)as novel markers of stress response and atherogenesis in children with chronic kidney disease(CKD)on conservative treatment[J].Cell Stress Chaperones,2011,16(1):97-103.
  • 3Whitesall SE,Hoff JB,Vollmer AP,et al.Comparison of si-multaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods[J].Am J Physiol Heart Circ Physiol,2004,286(6):H2408-2015.
  • 4Le J,Dauchot P,Perrot JL,etal.Quantitative zymography of matrix metalloproteinases by measuring hydroxyproline:ap-plication to gelatinases A and B [J].Electrophoresis,1999,20(14):2824-2829.
  • 5Zeisberg M,Khurana M,Rao VH,et al.Stage-specific action of matrix metalloproteinases influences progressive heredi-tary kidney disease [J].PLoS Med,2006,3(4):e100.
  • 6Uchio-Yamada K,Manabe N,Goto Y,et al.Decreased ex-pressinn of matrix metalloproteinases and tissue inhibitors of metalloproteinase in the kidneys of hereditary nephrotic(IC-GN)mice [J].J Vet Med Sci,2005,67(1):35-41.
  • 7Oliver GW,Leferson JD,Stetler-Stevenson WG,etal.Quan-titative reverse zymography:analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B re-verse zymograms[J].Anal Biochem,1997,244(1):161-166.
  • 8Androulakis E,Tousoulis D,Papageorgiou N,etal.The role of matrix metalloproteinases in essential hypertension[J].Curr Top Med Chem,2012,12(10):1149-1158.
  • 9Wasilewska A,Taranta-Janusz K,Zoch-Zwierz W,et al.Role of matrix metalloproteinases(MMP)and their tissue in-hibitors(TIMP)in nephrology[J].Przegl Lek,:2009,66(9):485-490.
  • 10Castro MM,Rizzi E,Prado CM,et al.Imbalance between matrix metalloproteinases and tissue inhibitor of metallopro-teinases in hypertensive vascular remodeling[J].Matrix Biol,2010,29(3):194-201.

二级参考文献8

  • 1王文,孙瑞成,任礼静,张秀娥,张会东,李新,马丽媛,刘力生.蛋白质摄入对卒中型自发性高血压大鼠脑卒中及繁育能力的影响[J].中国高血压杂志,1994,2(2):85-86. 被引量:2
  • 2王文,刘力生,张秀娥,金律,赵毅.尼莫的平对盐负荷SHRSP脑卒中的预防作用[J].中国循环杂志,1989,4(2):146-148. 被引量:4
  • 3王文 李新 刘力生.蛋白质、钾、钙、钠混合营养成分对SHRsp高血压靶器官的作用[J].中国循环杂志,1993,8:329-329.
  • 4Nomenclature Committee on hypertensive rat strain on the international society of hypertension revised nomenclature of hypertensive rat strains[J]. Hypertension, 1987,9:110.
  • 5Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke prone spontaneously hypertensive rat (SHR)[J]. Circ Res, 1974,34/35 (1), 143 - 155.
  • 6Yomori Y,Horie R,Sato M, et al. Pathogenetie similarity of stroke in stroke-prone SHR and humans[J ]. Stroke, 1976,7:46 - 53.
  • 7Ogata J. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension[J ]. Virch Arch, 1982,394:185.
  • 8曾贵云 王文 见刘力生 龚兰生 孔华宇主编.实验性高血压[A].见刘力生、龚兰生、孔华宇主编.临床高血压病学[C].天津:天津科技出版社,1990.75-79.

共引文献2

同被引文献43

  • 1赵岗,康侠明,张小彬,张爱仙.不同配比头孢哌酮钠舒巴坦钠体内抗菌作用研究[J].西北药学杂志,2006,21(5):212-214. 被引量:4
  • 2Arestegui A H, Fuquay R, Sirota J, et al. High altitude renal syndrome (Hars)[J]. J Am Soc Nephrol, 2011,22 (196) :3-8.
  • 3Haditsch B, Roessler A, Krisper P, et al. Volume regu- lation and renal function at high altitude across gender [J]. PLoS One, 2015,10(3) :e0118730.
  • 4Lorna G M, Susan N, Stacy Z. Human adaptation to high altitude: regional and life-cycle perspectives [ J ]. Yearb Phys Anthropol, 1998,107 ( $27 ) :25-64.
  • 5黄小玉,王荣,尹强,等.急进高原对Wistar大鼠体内甲氧氯普胺片剂药代动力学参数的影响[c].2014:184-185.
  • 6West J B. High-ahitude medicine[ J ]. Am J Respir Crit Care Med,2012,186(12) :29-37.
  • 7Goidfarb-Rumyantzev A S, Alper S L. Short-term respon- ses of the kidney to high altitude in mountain climbers [ J ]. Nephrol Dial Transplant, 2014,29 ( 3 ) :497-506.
  • 8Rinaldo B, John A K, Claudio R. Acute Kidney Injury [J].Lancet,2012,380(9843):756-766.
  • 9Ricci Z, Cruz D N, Ronco C. Classification and staging of acute kidney injury: Beyond the rifle and akin criteria [J]. Nat Rev Nephrol, 2011,7(4) :201-208.
  • 10Siew E D, Ware L B, Ikizler T A. Biological markers of acute kidney injury [ J]. J Am Soc Nephrol, 2011,22 (5) :810-820.

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部